Results 201 to 210 of about 108,295 (312)

Strategies to Identify Echocardiogram Complexity to Support Learning Echocardiogram Interpretation

open access: yesCanadian Journal of Cardiology
Thomas C. Raissi   +9 more
openaire   +2 more sources

Targeted Anti‐IL‐1 Immunomodulatory Therapy in Pediatric Onset PPP1R13L‐Related Arrhythmogenic Cardiomyopathy

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 8, Page 1807-1813, August 2026.
ABSTRACT Autosomal recessive loss‐of‐function variants in PPP1R13L cause an ultra‐rare cardiocutaneous syndrome characterized by rapidly progressive arrhythmogenic cardiomyopathy (ACM). PPP1R13L encodes iASPP, which has two potentially overlapping mechanisms driving ACM as both a regulator of NFκB‐mediated inflammation and a binding partner within the ...
Aaron Renberg   +9 more
wiley   +1 more source

Inferior Vena Cava Stenosis Mimicking Right Heart Failure in Carcinoid Heart Disease. [PDF]

open access: yesJACC Case Rep
Vila-Sanjuán S   +9 more
europepmc   +1 more source

Utility of Post‐Procedural HFA‐PEFF Reassessment for Long‐Term Heart Failure Risk Stratification After Atrial Fibrillation Ablation

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
In this single‐center cohort of 856 patients with preserved left ventricular ejection fraction undergoing atrial fibrillation ablation, post‐procedural HFA‐PEFF reassessment provided better long‐term discrimination for heart failure hospitalization than pre‐procedural assessment over a median 5.2‐year follow‐up.
Hironori Ishiguchi   +7 more
wiley   +1 more source

Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample. [PDF]

open access: yesStroke Vasc Neurol
Doshi S   +5 more
europepmc   +1 more source

Five‐Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study

open access: yesMuscle &Nerve, Volume 74, Issue 2, Page 397-403, August 2026.
ABSTRACT Aims We report 5‐year results from a phase 1/2a study of delandistrogene moxeparvovec, a recombinant adeno‐associated virus serotype rh74 vector‐based gene therapy for Duchenne muscular dystrophy (DMD), with post hoc analyses contextualizing functional outcomes. Methods Four ambulatory patients with DMD (≥ 4–< 8 years at enrollment) entered an
Jerry R. Mendell   +10 more
wiley   +1 more source

A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 15, Page 4321-4343, August 2026.
Abstract Background and Purpose Aberrant activation of type 2 ryanodine receptors (RyR2) causes lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Developing drugs that suppress RyR2 hyperactivation may be key to novel arrhythmia treatments.
Nagomi Kurebayashi   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy